The National Home Infusion Association (NHIA) will hold its first-ever home and specialty infusion payor summit November 2 in Dallas, TX. The event is designed to bring together leaders from commercial health insurance plans with home and specialty infusion experts to discuss how payors can better leverage home infusion to lower the total cost of care.
As part of a strategic focus on promoting health equity, The National Home Infusion Foundation (NHIF) recently adopted standardized categories for race and ethnicity data collection and is encouraging all providers to include voluntary questions to capture this data. NHIF will utilize this data throughout its projects to evaluate equitable access to infusion treatments in alternate sites.
Rep. Earl L. “Buddy” Carter (R-GA.), one of two pharmacists in Congress, penned an op-ed, “Four years later, Medicare policy is still failing home infusion therapy patients” recently published in The Hill. The article highlights flaws in CMS’ implementation of the Home Infusion Therapy Services benefit that is limiting access to these services.
Connect to the NHIA Community on the go by using the Connected Community mobile app, available for Apple or Android. Browse an activity feed of the latest going on across your communities, post and reply to discussion threads, search for resources and other content, and send and receive messages from other users.
Review the list of the top discussion topics to gain insight from professionals from around the NHIA Community on the most pertinent and timely issues of the past year. Learn what other infusion providers are considering and jump in to share your perspective as well!
The NHIA Community provides you several ways to be notified of updates in the community, allowing you to adjust the frequency and format of your notifications. This way you know, on your schedule, when new discussion posts and replies are added or when there is other news or announcements.
The NHIA Community has officially been supporting and connecting our members for one year. Although this is still just the early days of this incredible resource for the home and alternate site infusion industry, we have seen some amazing things during year one and have a lot more planned to continue to improve the platform and what it offers NHIA members.
Mark Wiencek, PhD, Contec, Inc.; Michael Bedenbaugh, PharmD, MBA, MS, Intramed Plus, Inc.; Lauren Pernot, BS, Contec, Inc.; Kate Douglass, MS, RN; Cognitive Design Associates
It is best practice to wipe down surfaces of supplies such as intravenous (IV) bags and vials packaged in cardboard boxes with a disinfectant before bringing the supplies into classified areas of a clean room. Effective decontamination of hazardous drug residues on containers such as IV bags may reduce the risk of occupational exposure. It is critical to understand the risk of penetration of any potential disinfecting or decontaminating agent into the IV bags.
Cheyenne Johnson, PharmD, Option Care Health; Daniel Decker, PharmD, MBA, BCACP, Option Care Health; Maria Giannakos, PharmD, MBA, BCPS, BCSCP, Option Care Health
Patients treated with intravenous (IV) vancomycin in the hospital often require outpatient parenteral antimicrobial therapy (OPAT) after discharge for the continuation of therapy. Despite vigilant monitoring, nephrotoxicity is a common adverse drug event associated with vancomycin in the home infusion setting.
Danell Haines, PhD, Research Consultant; Connie Sullivan, BSPharm, NHIA; Jennifer Charron, RN, MSN, MBA, NHIA
Patients in the 65+ age group and those receiving outpatient parenteral antimicrobial therapy (OPAT) in the home setting are increasing. There is a void in research that investigates OPAT satisfaction and outcomes in the 65+ age group. To better serve the home infusion needs of this population, an investigation of the patient’s OPAT success rate and understanding of home infusion instructions is needed. The purpose of this study is to determine if differences exist between OPAT patients aged 18-64 and 65+ in their understanding of home infusion instructions and their therapy success rate.
The National Home Infusion Association (NHIA) is pleased to announce that Michelle Simpson has recently earned the credential of Medical Writer Certified (MWC) after successfully completing the rigorous application and examination process developed and administered by the Medical Writing Certification Commission (MWCC) of the American Medical Writers Association (AMWA).
NHIA sent a letter to HHS requesting that the agency make permanent Medicare payment for COVID-19 monoclonal antibodies (mABs).
NHIF has adopted the Office of Management and Budget and Health and Human Services standard categories for race and ethnicity and urges all providers to include voluntary questions in their admissions process to capture this data.
On April 19, 2022, Baxter announced a supply disruption of the ExactaMix valve sets (ExactaMix 1200 Valve Set H938792 and ExactaMix 2400 Valve Set H938724) due to raw material constraints that are impacting production volumes. As a result, healthcare providers and institutions are driven to consider conservation measures when compounding using the ExactaMix Automated Compounder.
NHIA submitted comments on California SB 958, the Medication and Patient Safety Act of 2022, supporting amendments to the proposed legislation that allow for infused medications to be administered in the enrollee’s home when the physician and patient determine it is in the patient’s best interest and weighing in on various other aspects of the bill.
NHIA has compiled product shortage recommendations to help clinicians manage patient care and conserve prefilled NS syringe supplies during this time when they may not be readily available.
The National Home Infusion Foundation (NHIF) is proud to announce the publication of the first issue of Infusion Journal. The new scholarly journal features independent research and studies related to infused therapies, patient outcomes, medication safety, economic analyses, and case studies.
The National Home Infusion Association (NHIA) will hold its first-ever home and specialty infusion payor summit November 2 in Dallas, TX. The event is designed to bring together leaders from commercial health insurance plans with home and specialty infusion experts to discuss how payors can better leverage home infusion to lower the total cost of care.
As part of a strategic focus on promoting health equity, The National Home Infusion Foundation (NHIF) recently adopted standardized categories for race and ethnicity data collection and is encouraging all providers to include voluntary questions to capture this data. NHIF will utilize this data throughout its projects to evaluate equitable access to infusion treatments in alternate sites.
Rep. Earl L. “Buddy” Carter (R-GA.), one of two pharmacists in Congress, penned an op-ed, “Four years later, Medicare policy is still failing home infusion therapy patients” recently published in The Hill. The article highlights flaws in CMS’ implementation of the Home Infusion Therapy Services benefit that is limiting access to these services.
Connect to the NHIA Community on the go by using the Connected Community mobile app, available for Apple or Android. Browse an activity feed of the latest going on across your communities, post and reply to discussion threads, search for resources and other content, and send and receive messages from other users.
Review the list of the top discussion topics to gain insight from professionals from around the NHIA Community on the most pertinent and timely issues of the past year. Learn what other infusion providers are considering and jump in to share your perspective as well!
The NHIA Community provides you several ways to be notified of updates in the community, allowing you to adjust the frequency and format of your notifications. This way you know, on your schedule, when new discussion posts and replies are added or when there is other news or announcements.
The NHIA Community has officially been supporting and connecting our members for one year. Although this is still just the early days of this incredible resource for the home and alternate site infusion industry, we have seen some amazing things during year one and have a lot more planned to continue to improve the platform and what it offers NHIA members.
Mark Wiencek, PhD, Contec, Inc.; Michael Bedenbaugh, PharmD, MBA, MS, Intramed Plus, Inc.; Lauren Pernot, BS, Contec, Inc.; Kate Douglass, MS, RN; Cognitive Design Associates
It is best practice to wipe down surfaces of supplies such as intravenous (IV) bags and vials packaged in cardboard boxes with a disinfectant before bringing the supplies into classified areas of a clean room. Effective decontamination of hazardous drug residues on containers such as IV bags may reduce the risk of occupational exposure. It is critical to understand the risk of penetration of any potential disinfecting or decontaminating agent into the IV bags.
Cheyenne Johnson, PharmD, Option Care Health; Daniel Decker, PharmD, MBA, BCACP, Option Care Health; Maria Giannakos, PharmD, MBA, BCPS, BCSCP, Option Care Health
Patients treated with intravenous (IV) vancomycin in the hospital often require outpatient parenteral antimicrobial therapy (OPAT) after discharge for the continuation of therapy. Despite vigilant monitoring, nephrotoxicity is a common adverse drug event associated with vancomycin in the home infusion setting.
Danell Haines, PhD, Research Consultant; Connie Sullivan, BSPharm, NHIA; Jennifer Charron, RN, MSN, MBA, NHIA
Patients in the 65+ age group and those receiving outpatient parenteral antimicrobial therapy (OPAT) in the home setting are increasing. There is a void in research that investigates OPAT satisfaction and outcomes in the 65+ age group. To better serve the home infusion needs of this population, an investigation of the patient’s OPAT success rate and understanding of home infusion instructions is needed. The purpose of this study is to determine if differences exist between OPAT patients aged 18-64 and 65+ in their understanding of home infusion instructions and their therapy success rate.
The National Home Infusion Association (NHIA) is pleased to announce that Michelle Simpson has recently earned the credential of Medical Writer Certified (MWC) after successfully completing the rigorous application and examination process developed and administered by the Medical Writing Certification Commission (MWCC) of the American Medical Writers Association (AMWA).
NHIA sent a letter to HHS requesting that the agency make permanent Medicare payment for COVID-19 monoclonal antibodies (mABs).
NHIF has adopted the Office of Management and Budget and Health and Human Services standard categories for race and ethnicity and urges all providers to include voluntary questions in their admissions process to capture this data.
On April 19, 2022, Baxter announced a supply disruption of the ExactaMix valve sets (ExactaMix 1200 Valve Set H938792 and ExactaMix 2400 Valve Set H938724) due to raw material constraints that are impacting production volumes. As a result, healthcare providers and institutions are driven to consider conservation measures when compounding using the ExactaMix Automated Compounder.
NHIA submitted comments on California SB 958, the Medication and Patient Safety Act of 2022, supporting amendments to the proposed legislation that allow for infused medications to be administered in the enrollee’s home when the physician and patient determine it is in the patient’s best interest and weighing in on various other aspects of the bill.
NHIA has compiled product shortage recommendations to help clinicians manage patient care and conserve prefilled NS syringe supplies during this time when they may not be readily available.
The National Home Infusion Foundation (NHIF) is proud to announce the publication of the first issue of Infusion Journal. The new scholarly journal features independent research and studies related to infused therapies, patient outcomes, medication safety, economic analyses, and case studies.
